AdvertisementDelaware-based NiKang Therapeutics Inc. completed an oversubscribed $200 million series C financing. Last year, the company received $50 million in series B financing. “We are thrilled to have such an … Continue reading Delaware-based NiKang Theraputics secures $200 million in series B funding